Drug Profile
Streptococcal A vaccine - Emergent BioSolutions
Latest Information Update: 07 Feb 2008
Price :
$50
*
At a glance
- Originator Emergent Product Development UK
- Class Streptococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Streptococcal infections
Most Recent Events
- 30 Nov 2000 Preclinical development for Streptococcal infections in United Kingdom (Unknown route)